NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (NASDAQ: SDIX) - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, today reported financial results for the quarter and six months ended June 30, 2008. Revenues for the quarter decreased 2% to $6.6 million, compared to $6.7 million for the same period in 2007. Revenues for the second quarter of 2008 were positively impacted by a 16% year-over-year increase in sales of Food Pathogen products, a 19% year-over-year increase in sales of Water and Environmental products and a 121% year-over-year increase in Genomic Antibody Technology™ (GAT™) products. These solid gains were offset by a 50% decline in the Bulk Antibody business.
